UP!

SXC $10.94

SXC target price
10.94
0
0

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q3 2022 2022-10-31 Future report Set alerts
Q2 2022 2022-08-02 0.21 0.21
Q1 2022 2022-05-02 0.35 0.35
Q4 2021 2022-02-01 0.15 0.15
Q3 2021 2021-11-01 0.27 0.27
Q2 2021 2021-07-29 -0.11 -0.11
Q1 2021 2021-04-28 0.20 0.20
Q4 2020 2021-02-04 -0.09 -0.09
Q3 2020 2020-11-06 -0.04 -0.03
Q2 2020 2020-08-03 0.08 0.08

Ratings

2016-04-07 Reiterated Rating FBR & Co. Buy $9.00
2016-04-07 Reiterated Rating FBR & Co Buy $9.00
2016-03-17 Reiterated Rating Bank of America Underperform
2016-03-17 Reiterated Rating Bank of America Corp. Underperform
2015-12-09 Downgrade Bank of America Neutral to Underperform
2015-12-02 Downgrade Clarkson Capital Buy to Neutral
2015-10-13 Downgrade Bank of America Buy to Neutral $9.00
2015-10-13 Lower Price Target BB&T Corp. Buy $20.00 to $16.00
2015-09-18 Initiated Coverage FBR & Co. Outperform $18.00
2015-07-22 Lower Price Target BB&T Corp. Buy $25.00 to $20.00
2015-06-01 Initiated Coverage Goldman Sachs Buy $19.00
2015-06-01 Initiated Coverage Goldman Sachs Group Inc. Buy $19.00
2015-04-15 Lower Price Target JPMorgan Chase & Co. Neutral $33.00 to $27.00
2015-01-15 Reiterated Rating Brean Capital Buy $24.00
2014-12-30 Upgrade Credit Suisse Neutral to Outperform
2014-12-30 Upgrade Credit Suisse Group AG Neutral to Outperform
2014-12-17 Upgrade Credit Suisse Neutral to Outperform $26.00 to $22.00
2014-11-25 Downgrade Goldman Sachs Conviction-Buy to Buy
2014-10-27 Upgrade BB&T Capital Mkts Hold to Buy $30
2014-10-27 Upgrade BB&T Corp. Hold to Buy $30.00
2014-09-17 Reiterated Rating Bank of America Buy $26.00 to $28.00
2014-08-21 Boost Price Target Brean Capital Buy $26.00 to $28.00
2014-08-20 Downgrade Credit Suisse Outperform to Neutral $26.00
2014-06-27 Reiterated Rating Goldman Sachs Buy to Conviction-Buy
2014-05-16 Lower Price Target Goldman Sachs Buy $27.00 to $26.00
2014-05-13 Reiterated Rating Barclays Equal Weight $21.00 to $22.00
2014-03-17 Reiterated Rating Goldman Sachs Buy
2014-01-31 Upgrade Credit Suisse Neutral to Outperform $19.00 to $24.00
2014-01-31 Boost Price Target Brean Capital Buy $23.00 to $26.00
2013-12-17 Downgrade Credit Suisse Outperform to Neutral $19.00
2013-12-13 Upgrade Bank of America Neutral to Buy $20.00 to $25.00
2013-10-28 Boost Price Target Barclays Equal Weight $19.00 to $21.00
2013-10-10 Reiterated Rating Goldman Sachs Buy
2013-09-27 Reiterated Rating Goldman Sachs Buy $22.00
2012-02-02 Downgrade KeyBanc Capital Mkts Buy to Hold $15
2011-12-16 Initiated KeyBanc Capital Mkts Buy $15
2011-12-08 Initiated Oppenheimer Outperform $15
2016-04-07 Reiterated Rating FBR & Co. Buy $9.00
2016-04-07 Reiterated Rating FBR & Co Buy $9.00
2016-03-17 Reiterated Rating Bank of America Underperform
2016-03-17 Reiterated Rating Bank of America Corp. Underperform
2015-12-09 Downgrade Bank of America Neutral to Underperform

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
Mangrove Partners Master Fund, Ltd. 9.16%  (6348923) ASFI / CLMS / FSAM / MDLY / SXC / WLB /
Sun Coal & Coke LLC 7.07%  (4904752) SXC / SXCP /
Henderson Frederick A. Chairman & CEO 0.38%  (261860) CPWR / MAR / SXC / SXCP /
Thomson Michael J President & COO 0.22%  (150848) SXC / SXCP /
Hardesty Phillip Michael Senior Vice President 0.10%  (67983) SXC /
HAMILTON PETER B 0.09%  (65845) OSK / SE / SXC /
DARNALL ROBERT J 0.08%  (57572) SXC /
Yeaw Gary P Senior Vice President 0.06%  (44070) SXC /
PEISER ROBERT A 0.04%  (26345) SR / SXC / TISI / USAK /
AFRICK ANDREW 0.04%  (26345) ALQA / RPXC / STRI / SXC /
West Fay Vice President & Controller 0.04%  (26305) KWR / SXC /
Newman Mark Senior Vice President & CFO 0.02%  (15130) MO / SXC / SXCP /
Cade Denise R SVP and General Counsel 0.02%  (11241) IEX / SXC /
Gates Katherine T Sr VP & General Counsel 0.01%  (7916) SXC /
Lausas Allison S Vice President & Controller 0.01%  (5006) SXC /